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ABSTRACT
DNA methylation is an epigenetic modification that
plays an important role in gene regulation. It can be
influenced by stochastic events, environmental
factors and developmental programs. However,
little is known about the natural variation of gene-
specific methylation patterns. In this study, we
performed quantitative methylation analyses of six
differentially methylated imprinted genes (H19,
MEG3, LIT1, NESP55, PEG3 and SNRPN), one
hypermethylated pluripotency gene (OCT4) and
one hypomethylated tumor suppressor gene (APC)
in chorionic villus, fetal and adult cortex, and adult
blood samples. Both average methylation level and
range of methylation variation depended on the
gene locus, tissue type and/or developmental stage.
We found considerable variability of functionally
important methylation patterns among unrelated
healthy individuals and a trend toward more similar
methylation levels in monozygotic twins than in
dizygotic twins. Imprinted genes showed relatively
little methylation changes associated with aging in
individuals who are >25 years. The relative differ-
ences in methylation among neighboring CpGs in
the generally hypomethylated APC promoter may
not only reflect stochastic fluctuations but also
depend on the tissue type. Our results are consis-
tent with the view that most methylation variation
may arise after fertilization, leading to epigenetic
mosaicism.
INTRODUCTION
It is becoming increasingly clear that DNA sequence vari-
ations and environmental factors alone cannot account
for the phenotypic differences among individuals. Studies
in genetically identical organisms, i.e. monozygotic twins,
isogenic animal strains and cloned animals implicated
non-DNA sequence and non-environment-based effects
as a main source of phenotypic variation (1–4). After
genes and environment, epigenetic factors, in particular
DNA methylation, may form the molecular basis of
this ‘third component’. Much of the existing DNA
methylation variation may result from stochastic events
during epigenetic reprogramming in gametogenesis, early
embryogenesis and later developmental processes. This
spontaneous epimutation rate can be modified by genetic
and environmental factors (5–7). It is estimated that
epimutations occur 100 times more frequently than
somatic DNA mutations (8,9).
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Epigenetic information is not encoded by the DNA
sequence itself but by reversible modifications of DNA
and/or histones, that can be transmitted from cells to
daughter cells and sometimes even from one generation
to another (7,10). Methylation of the 50-cytosine residues
in CpG dinucleotides directly targets DNA. It is
associated with posttranslational histone modifications
that lead to a locally condensed inactive chromatin struc-
ture (11,12). One important component of epigenetic gene
regulation are CpG islands (CGIs) that are 500–2000 bp
long and associated with promoters in most mammalian
genes. Most CpGs in promoters are protected from
methylation in somatic tissues. Promoter methylation
leads to stable gene silencing during development/differ-
entiation and in disease processes (13–15). For example,
pluripotency genes switch from a demethylated and
transcriptionally active state in embryonic cells to a fully
methylated repressed state in somatic cells (16,17). In
contrast, tumor suppressor genes are demethylated and
active in somatic cells; ectopic methylation begins
early in tumorigenesis (18–20). Genomic imprinting is
a parent-specific epigenetic modification in which allele-
specific expression depends on male versus female
germline transmission. The differentially methylated
regions (DMRs) of imprinted genes are involved in the
control of parental allele-specific gene activity (21,22).
Genomic DNA methylation patterns may exhibit con-
siderable variation among human individuals, as well as
intraindividual changes over time (23–26). Large-scale
epigenome mapping revealed that CpG-rich regions
exhibit substantially less interindividual variation of
DNA methylation patterns than CpG-poor regions.
Most CGIs showed relatively similar low methylation
levels in all individuals, with a few methylated CpGs
randomly distributed among the many unmethylated
CpGs (27). This is consistent with the view that the
density of methylated CpGs in a cis-regulatory region
(rather than individual CpGs, i.e. in transcription factor
binding sites) turns a gene ‘on’ or ‘off’ (15,28). It is well-
known that epigenetic gene silencing during tumor initia-
tion and progression involves methylation of entire CGIs
but not single critical CpGs (18–20). It is plausible to
assume that epigenetic variation contributes significantly
to both phenotypic variation among individuals and
human disease (7,14,29). However, in order to associate
unexpected methylation levels of developmentally impor-
tant genes with disease processes, it is crucial to assess the
normal range of methylation variation. Using quantitative
methylation assays, we measured the methylation levels in
cis-regulatory regions of imprinted, pluripotency and
tumor suppressor genes in different tissues and/or
developmental states.
MATERIALS AND METHODS
Tissue samples and DNA preparation
Blood samples were obtained with informed consent from
12 healthy monozygotic and 14 dizygotic twin pairs as well
as from unrelated individuals. Chorionic villus samples
(CVS) of 48 term placentas of healthy newborns were
obtained with informed consent of the mothers from the
Department of Gynecology and Obstetrics, Mainz
University. Sperm samples of 45 males with normal
spermiograms (according to WHO guidelines) were
obtained with informed consent of the donors from the
Fertility Center Wiesbaden.
In addition, we analyzed native chorionic villi from 29
first-trimester spontaneous abortions and 12 cultured
CVS. Ten fetal brain samples (frontal cortex) were
obtained from spontaneous abortions and stillbirths that
underwent pathomorphological examination at the
Department of Paediatric Pathology, Mainz University.
Following diagnostics, the excess samples were made
anonymous. Placental and fetal tissues were taken only
from pregnancies without detectable chromosome and
fetal abnormalities. Tissues were dissected within 24 h
after abortion/stillbirth and stored at 80C until
further analysis. Adult brain samples from 12 humans
between 24 and 83 years of age were obtained from
the Institute of Legal Medicine and the Department
of Neuropathology, Mainz University. Causes of death
reflected accidents and a wide spectrum of common
diseases (e.g. cardiovascular disease). Medical history and
histological examination revealed no evidence for heredi-
tary brain disorders. After removal of meninges frontal
cortex tissue (area A10) was dissected between 1–2 days
postmortem and immediately frozen and stored at 80C.
Use of anonymized excess tissue materials (from
pathomorphological diagnostics) for scientific analyses was
approved by the local ethics committee [Aerztekammer
Rheinland-Pfalz, Decisions No. 837.103.04 (4261) and
837.073.07 (5608)].
The DNeasy Blood and Tissue Kit (Qiagen, Hilden
Germany) was used for genomic DNA isolation. Sperm
samples were first purified with Pure Sperm 40/80
(Nidacon, Molndal, Sweden) and and then treated with
100mM Tris–Cl, 10mM EDTA, 500mM NaCl, 1% SDS
and 2% b-mercaptoethanol. After incubation for 2 h at
56C with proteinase K, DNA was prepared, as described
above.
Studied genes
The DMRs of two paternally methylated (H19 and
MEG3) and four maternally methylated (LIT1, NESP55,
PEG3 and SNRPN) genes as well as the promoters of the
pluripotency gene OCT4 and the tumor suppressor gene
APC were analyzed by bisulfite pyrosequencing.
Amplicons targeting methylation-dependent cis-regula-
tory regions of these well-studied genes were chosen
from the literature (30–35). Although the gene-specific
pyrosequencing assays are based on only a small number
(2–7) of CpGs per gene, the analyzed sites are thought to
be representative of a given DMR or promoter. Individual
CpGs in larger CGIs cannot stably maintain methylation
states that differ from those of the neighboring CpGs.
Usually, the entire CGI is either methylated or
demethylated (27,28). PCR and sequencing primers
(Table 1) were designed with the Pyrosequencing
Assay Design Software (Biotage). A single nucleotide
polymorphism (SNP), rs2107425, with approximately
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50% heterozygosity is located at the 4th base from 50-end
of the nested reverse primer for H19. In previously pub-
lished methylation analyses (30) and also in our own expe-
rience, this A to G change did not cause a biased
amplification of DNA methylation. The binding sites for
the other studied genes do not contain known SNPs.
Although we cannot entirely exclude that the one or
other analyzed sample displays a novel allelic sequence
variation, such rare variants, if any, cannot explain the
observed methylation variation of imprinted genes.
Imprinting of the paternally expressed IGF2 gene and
the maternally expressed non-protein-coding H19 gene
on chromosome 11p15 is regulated by differentially
methylated CCCTC binding factor sites in the 50-region
ofH19 (36). Methylation disturbances in theH19 germline
DMR lead to dysregulation of IGF2-H19 imprinting and
intrauterine growth retardation (Silver–Russell syndrome)
(37) and overgrowth (Beckwith–Wiedemann syndrome)
(38), respectively. The germline DMR within intron 10
of the KCNQ1 gene regulates expression of the paternally
expressed KCNQ1OT1 (LIT1) transcript and the mater-
nally expressed CDKN1C gene on chromosome 11p15.
Epimutations in this LIT1 DMR are also associated with
Beckwith–Wiedemann syndrome (39). The methylation
status of the germline DMR in the SNRPN promoter/
exon 1 is important for imprint establishment/mainte-
nance of genes in the Prader-Willi/Angelman syndrome
region (40). The PEG3 gene on chromosome 19q13.4 is
paternally expressed in embryo and placenta and can
induce apoptosis. It has a DMR in its promoter region
(41). The maternally expressed non-coding MEG3 RNA
represents a growth suppressor. Hypomethylation of the
MEG3 promoter on chromosome 14q32.2 is associated
with low-birth weight, muscular hypotonia and various
dysmorphisms (35). The GNAS locus on chromosome
20q13.3 has a highly complex imprinting pattern. Its dif-
ferent products (Gsalpha, XLalphas and NESP55) are
involved in early postnatal adaptions and neuroendocrine
functions. NESP55 is expressed from the maternal chro-
mosome in restricted brain areas (42).
The transcription factor OCT4 (POU5F1) is the key
gene for maintaining pluripotency in mammalian
cells (43). It is highly expressed in human oocytes,
down-regulated in early embryos, and then expressed
de novo from the embryonic genome in blastocysts.
Differentiation of the somatic tissues is associated
with downregulation of OCT4 (44). Germline mutations
in the APC tumor suppressor gene cause famil-
ial adenomatous polyposis, a hereditary cancer
syndrome. Somatic inactivation of APC by promoter
hypermethylation is frequently seen in sporadic colorectal
cancers (18).
Bisulfite pyrosequencing
Bisulfite treatment of genomic DNA was performed using
the EpiTect Bisulfite Kit (Qiagen, Hilden, Germany).
The PCR reaction mixture consisted of 2.5ml 10 PCR
buffer, 2.5 ml 50mM MgCl2, 2.5 ml 10mM dNTP mix,
1.0 ml (100 ng) of each forward and reverse primer, 0.5 ml
(2.5U) FastStart Taq DNA Polymerase (Roche
Diagnostics, Mannheim, Germany), 14 ml PCR-grade
Table 1. Genes and primers for pyrosequencing
Gene Primer Sequence (50–30) Amplicon
length (bp)
Chromosomal
localization (bp)
Number
of CpGs
Reference
H19 Outer forward TTTTTGGTAGGTATAGAGTT 231 Chromosome 11
1 977 647-1 977 878
4 El-Maarri et al. (30)
Outer reverse AAACCATAACACTAAAACCC
Nested forward TGTATAGTATATGGGTATTTTTGGAGGTTT
Nested reverse* TCCTATAAATATCCTATTCCCAAATAACC
Sequencing TGGTTGTAGTTGTGGAAT
MEG3 Forward GATTTTTTTTATATATTGTGTTTG 220 Chromosome 14
100 361 907-100 362 129
3 Zechner et al. (35)
Reverse* CTCATTTCTCTAAAAATAATTAACC
Sequencing GTGTTTGAATTTATTTTGTTTGG
LIT1 Forward AATTAGTAGGTGGGGGG 122 Chromosome 11
2 677 751-2 677 873
2 Mackay et al. (31)
Reverse* CTAAAAAACTCCCTAAAAATC
Sequencing GGGGGTAGTYGGAG
NESP55 Outer forward TTTTTTATTTTATAGGGTGTATTT 343 Chromosome 20
56 848 506-56 848 849
3 El-Maarri et al. (30)
Outer reverse AAAATAAAATACTTAAACACCAC
Nested forward TTTTTGTAGAGTTAGAGGGTAGGT
Nested reverse* AAAAAAAACAACTCAAAATCTACC
Sequencing GTGTTTAAGAGGATGGAT
PEG3 Forward GGTGTAGAAGTTTGGGTAGTTG 153 Chromosome 19
62 043 756-62 043 909
4 Mackay et al. (31)
Reverse* CTCACCTCACCTCAATACTAC
Sequencing TGTTTATTTTGGGTTGGT
SNRPN Forward* AGGGAGTTGGGATTTTTGTATT 237 Chromosome 15
22 751 105-22 751 342
White et al. (32)
Reverse CCCAAACTATCTCTTAAAAAAAAC 2 3=6
Sequencing 1 ACACAACTAACCTTACCC 3
Sequencing 2 CCAACCTACCTCTAC 3
OCT4 Forward AAGTTTTTGTGGGGGATTTGTAT 185 Chromosome 6
31 246 461-31 246 646
2 Deb-Rinker et al. (33)
Reverse* CCACCCACTAACCTTAACCTCTA
Sequencing TGAGGTTTTGGAGGG
APC Forward* GGTTAGGGTTAGGTAGGTTGT 193 Chromosome 5
112 101 274-112 101 467
7 Schatz et al. (34)
Reverse ACTACACCAATACAACCACATATC
Sequencing CCACACCCAACCAA
This table provides the primer sequences for bisulfite pyrosequencing of our studied genes, the length and chromosomal localization (according to
ensembl 54, May 2009) of the amplified segments, and the number of CpG sites in the amplicons. Biotinylated primers are indicated by star symbols.
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water and 100 ng template DNA. PCR amplifications were
carried out with an initial denaturation step at 94C for
3min, 35–45 cycles of 94C for 30 s, primer-specific
annealing temperature for 30 s, 72C for 60 s,
and a final extension step at 72C for 10min. Bisulfite
pyrosequencing was performed on a PSQ96MA
Pyrosequencing System (Biotage, Uppsala, Sweden) with
the PyroGold SQA reagent kit (Biotage) (45). The Pyro
Q-CpG software (Biotage) was used for data analysis.
To demonstrate the reliability of our quantitative
methylation assays, we performed duplicate tests for a
subset of tissue samples (mainly samples representing
outliers in the box plot analysis). The methylation differ-
ence between duplicate measurements was 2.7±1.6%
for H19 (12 samples tested), 1.4±0.9% for MEG3
(13 samples), 2.5±1.5% for LIT1 (11 samples),
1.8±1.1% for NESP55 (14 samples), 1.9±1.4% for
PEG3 (19 samples), 1.1±0.9% for SNRPN (10
samples), 1.1±1.1% for OCT4 (3 samples), and
1.1±0.6% for APC (14 samples).
Data analysis
Quantitative methylation data were analyzed with SPSS
version 17.0.1 (http://www.spss.com). Box plots were
generated using the default parameters of SPSS. They
display the location, dispersion and skewness of a set of
data. The bottom and the top of the box indicate the 25th
and 75th percentile, respectively. The T bars extend from
the boxes to at most 1.5 times the height of the box.
Outliers are samples that do not lie within these T bars,
extreme outliers have values more extreme than three
times the box length away from the median. Samples
falling in the T bars were considered to be normally
methylated, whereas outliers (and extreme outliers) may
represent extreme methylation values. The 2-test was
used to compare the proportion of outliers in different
tissues. A P< 5% was considered significant.
Statistical inference concerning the methylation data
sets for the eight studied genes between different tis-
sues was done with a multivariate analysis of variance
(MANOVA), which is generalization of common
analysis of variance. T-test was used to compare the
methylation values of a particular gene between two
groups.
Scatter plots were used to visualize the relationship
between the DNA methylation levels (of a given gene) in
unrelated blood samples and the age of the examined indi-
viduals. A linear regression was calculated to infer
the dependence of methylation percentage on age. The
goodness of fit measure (R2) was used to quantify this
relation. R2 can range from +1 (perfect linear depen-
dence) to 0 (no correlation). The P-value was calculated
by ANOVA. It determines whether or not R2 significantly
differs from 0.
We plotted a receiver operating characteristics (ROC)
curve for the six studied imprinted genes, comparing the
pairwise methylation differences of monozygotic (MZ)
and dizygotic (DZ) twins. Using the area under curve as
a test statistic for discriminative power, the corresponding
P-value is exactly that obtained by a Wilcoxon rank sum
test. In addition, a multivariate discrimination analysis
(Fisher’s linear discriminant analysis) including the
methylation data sets of the six studied genes was per-
formed. The non-parametric Wilcoxon test was then
used to compare the pairwise methylation differences of
two groups (MZ versus DZ).
PAM analysis (46) was used to assess whether the
methylation pattern across seven neighboring CpG sites
in the APC promoter is predictive of the tissue type. By
pattern we mean the relative difference in the methylation
values among the seven CpGs. The input data were the
mean-centered methylation data of all samples.
RESULTS
Gene-, tissue- and developmental stage-dependent
variation of DNA methylation
Here, we determined the methylation percentages of
six DMRs (H19, MEG3, LIT1, NESP55, PEG3 and
SNRPN) and two promoters (OCT4 and APC) in
chorionic villi from 48 healthy newborns, in 10 fetal and
12 adult cortices, and 26 adult blood samples. As
expected, imprinted genes were differentially methylated
with median methylation values ranging from 37% to
53%, OCT4 was hypermethylated with median
methylation values from 88% to 97%, and APC was
hypomethylated with median methylation values from
4% to 7% (Table 2). The box plots in Figure 1 demon-
strate that the median methylation of DMRs and pro-
moters as well as the range of methylation variation are
dependent on the gene, tissue type and developmental
stage. For example, the median H19 DMR methylation
ranged from 43% in adult blood to 52% in adult brain,
whereas the median SNRPN methylation ranged from
36% in adult blood to 41% in CVS. Compared to the
developing fetal brain, H19 and LIT1 were >5%
upmethylated, whereas MEG3 was >5% downmethylated
in adult brain.
When only looking at the six imprinted genes, which
have been studied in all tissues, CVS displayed 5%, fetal
brain 17%, adult brain 7% and adult blood samples 1%
extreme DMR methylation values (Table 2). The number
of outliers (including extreme outliers) in blood samples
was significantly lower (2-test, P< 0.05) than in any other
studied tissue. The difference between CVS and fetal brain
was also significant. Three of 48 (6%) CVS, one of 10
(10%) fetal cortices, two of 13 (15%) adult cortices, but
none (0%) of 25 adult blood samples displayed extreme
DMR methylation values in two or more imprinted genes.
In one fetal cortex 5 of the 6 studied DMRs were
hypermethylated. Collectively, these data suggest that
methylation imprints are relatively tightly regulated in
blood, whereas CVS and brain exhibit considerably
more methylation variation, consistent with a relaxation
of imprinting (DMR methylation). With the notable
exception of one CVS with extreme (40%) OCT4
hypomethylation, the pluripotency gene OCT4 was
hypermethylated (83–98%) and the tumor suppressor
gene APC was hypomethylated (2–11%) in all analyzed
tissue samples.
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In addition, we performed a MANOVA for each
studied gene to test for differences between the
methylation data sets of CVS, fetal brain, adult brain
and adult blood. The null hypothesis that there are no
differences between tissues was clearly rejected (Wilks’
Lambda test, P< 0.001) for H19, MEG3, PEG3,
SNRPN and APC. There was a trend (P=0.05)
for LIT1. Group-wise comparisons revealed significant
(t-test, P< 0.05) H19 methylation differences between
CVS and adult blood, between fetal cortex and adult
blood, as well as between adult cortex and adult blood.
MEG3 methylation differences were found between CVS
and fetal cortex, between fetal and adult cortex, and
between fetal cortex and adult blood; PEG3 methylation
differences between CVS and adult cortex, between CVS
and adult blood, and between adult cortex and blood;
SNRPN methylation differences between CVS and adult
blood and between adult cortex and blood; APC
methylation differed between fetal and adult cortex and
between fetal cortex and adult blood.
Methylation changes with age
A general decrease in DNA methylation with age has been
reported in blood cells (25). When we plotted the
measured methylation values of six imprinted genes in
blood samples against age (between 21 and 72 years) of
the donor and calculated the linear regression (Figure 2A),
there was a significant decrease of methylation with age
for H19 (R2=0.264; P=0.003 that there is no correla-
tion between methylation and age), MEG3 (R2=0.535;
P< 0.001), LIT1 (R2=0.241; P=0.006), NESP55
(R2=0.310; P=0.001) and SNRPN (R2=0.133;
P=0.037). However, this age effect was completely lost
when removing all data points between 21 and 25 years
(Figure 2B). T-test revealed highly significant (P< 0.001)
differences in H19, MEG3, LIT1, NESP55 and SNRPN
methylation between younger individuals (up to 25 years)
and those >25 years.
Methylation variation in monozygotic and dizygotic twins
Figure 3A displays the differences in DMR methylation in
blood samples of 12 MZ and 14 DZ pairs. For all six stud-
ied imprinted genes, the (median) pairwise methylation
difference between MZ was somewhat smaller than
between DZ. Because of the small number of studied
twin pairs, there was no significant difference between
the MZ and DZ groups at the single gene level.
However, when a ROC curve (Figure 3B) was calculated
with the methylation data sets of all six studied genes
(including outliers), there was a significant (Wilcoxon
test, P=0.038) difference between MZ and DZ. A
multivariate discrimination analysis based on the
pairwise methylation differences of the six studied genes
correctly classified 86% of the MZ and 88% of the DZ.
This supports the assumption that the methylation differ-
ences of imprinted genes between pairs are predictive of
the mode of twinning. The age of the MZ ranged from
27 to 70 years (mean 43 years), whereas the age of the DZ
ranged from 38 to 72 years (mean 55 years). Although
we cannot exclude age as a confounding variable, the
observation that DMR methylation is rather stable
between 27 and 72 years (Figure 2B) argues against this
possibility.
Methylation patterns of neighboring CpG sites
Our pyrosequencing assay for the tumor suppressor APC
targets seven neighboring CpGs. With the notable excep-
tion of placenta (native CVS), the analyzed region of the
APC promoter was hypomethylated in all tissues
(Figure 4A). Native placental villi (n=29) displayed a
much higher CGI methylation (median 37%) than
cultured CVS (n=12, median 10%). The maternal APC
allele has been reported to be methylated in the placenta
(47), implying that cell culture leads to a loss of APC
methylation (maternal imprinting). Adult cortex
(n=12), blood (n=26), and sperm (n=45) samples
displayed median methylation values of 8%, 6% and
4%, respectively. By visual inspection of the fluctuation
Table 2. Median methylation and number of extreme methylation values in different tissues
Gene Fetal cortex Adult cortex Newborn CVS Adult blood
Median
methylation
Number of
outliers
Median
methylation
Number of
outliers
Median
methylation
Number of
outliers
Median
methylation
Number of
outliers
H19 47% 1/10 52% 0/13 44% 1/45 43% 0/22
MEG3 51% 0/9 45% 1/10 44% 1/47 46% 0/25
LIT1 46% 2/10 53% 0/13 48% 4/40 49% 0/20
NESP55 43% 1/10 39% 2/13 42% 0/33 43% 0/24
PEG3 40% 1/10 42% 1/13 45% 3/48 48% 1/25
SNRPN 40% 2/9 40% 1/13 41% 4/34 36% 0/25
OCT4 ND ND 97% 1/13 88% 1/12 94% 1/12
APC 4% 0/10 7% 0/8 ND ND 6% 1/26
Imprinted genes 7/58 (17%) 5/75 (7%) 13/247 (5%) 1/141 (1%)
Samples with outliers 3/10 (30%) 3/13 (23%) 10/48 (21%) 3/25 (12%)
Samples with outliers in
multiple genes
1/10 (10%) 2/13 (15%) 3/48 (6%) 0/25 (0%)
This table presents the median methylation (of all analyzed CpGs) and the number of outliers (including extreme outliers) in the studied DMRs and
promoters in chorionic villi (of healthy newborns), fetal and adult cortex, and adult blood. ND, not done.
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of methylation levels across the seven studied CpG sites
(Figure 4A), CpGs 2, 3, 6 and 7 appeared to be most
predictive of the tissue type. When we used Fisher’s
discriminant analysis including the methylation data sets
of these four CpGs 80% of the adult blood, 82% of adult
cortex, 58% of cultured CVS, 100% of native CVS and
76% of sperm samples were classified correctly from the
other tissues. In addition, we performed a PAM analysis
(Figure 4B) to assess whether the methylation pattern
across the seven analyzed CpGs (relative to each other)
is predictive of the tissue type. It turned out that native
CVS can be distinguished properly from the rest of the
tissues. Any further distinction based upon the shrunken
centroid classifier was not possible, because in the
remaining cases the classifier mostly decided for ‘sperm’,
irrespective of the true tissue origin.
DISCUSSION
In contrast to the genome of an individual which is deter-
mined for all cells of the body at the time of conception,
the epigenome is highly dynamic and differs from tissue to
tissue. The most dramatic epigenetic changes occur during
genome-wide reprogramming in gametogenesis and early
embryogenesis (48,49). Genome-wide demethylation in the
primordial germ cells erases essentially all methylation
patterns to ensure an equivalent epigenetic state in germ
cells of both sexes. Parent-specific methylation patterns
according to the sex or the germline are then estab-
lished during germ-cell differention (50). Genome-wide
demethylation waves in the early embryo erase most
germline methylation patterns, followed by de novo
methylation and establishment of somatic methylation
patterns (48,51). In addition to the carefully directed
Figure 1. Median methylation and range of methylation variation of two paternally methylated DMRs, H19 and MEG3, and four maternally
methylated DMRs, LIT1, NESP55, SNRPN and PEG3, of imprinted genes as well as of promoters of one pluripotency gene, OCT4, and one tumor
suppressor gene, APC. The box plots of a given gene show the distribution of DMR or promoter methylation values in 48 CVS from healthy
newborns, 10 fetal and 12 adult brain samples, and 26 adult blood samples from unrelated individuals. The median is represented by a horizontal
line. The bottom of the box indicates the 25th percentile, the top the 75th percentile. Outliers are shown as open circles, extreme outliers as stars.
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epigenetic reprogramming processes during develop-
ment, epigenetic modifications may occur randomly
or in response to environmental influences and ageing
(5–7,23–25,29). Epigenetic variation may not only contrib-
ute substantially to phenotypic differences among individ-
uals but also play an important role in the etiology
of common (complex) human disease (52–54). This is obvi-
ous in most cancers which display dramatically increased
methylation of tumor suppressor genes (18–20).
Although there is no simple linear relationship between
DNA methylation and gene activity and the regulatory
mechanisms may differ from gene to gene, in general
the level and/or pattern of methylation in cis-regulatory
regions is thought to control chromatin conformation and
transcriptional potential. Threshold models suggest
that changes shifting CpG methylation above a critical
density lead to gene silencing (27,55). Our quantita-
tive study revealed considerable variation in DNA
methylation in hypomethylated, differentially methylated
or hypermethylated cis-regulatory regions that are directly
or indirectly involved in the control of gene activity.
Both the average methylation level and the range
of methylation variation depend on gene locus, tissue
type and development stage, and age. It is noteworthy
that the analyzed CVS and blood samples were
from healthy newborns and adults; the brain samples
were from fetuses and adults without detectable
brain pathology. The lowest and the highest DMR
methylation values in individual samples were 36% (in
an adult blood) and 65% (in a fetal brain) for H19,
25% (in an adult brain) and 75% (in a fetal brain) for
MEG3, 32% (in a CVS) and 67% (in a fetal brain) for
LIT1, 24% and 68% (both in adult brain) for NESP55,
37% (in an adult brain) and 64% (in a fetal brain) for
PEG3, and 21% (in a fetal brain) and 55% (in a CVS)
for SNRPN. These functionally important methylation
patterns exhibit a high degree of interindividual variability
that by far exceeds DNA sequence variation. This
enormous epigenetic variability cannot be explained by
experimental noise, which is in the order of 1–2% discrep-
ancy between the measured methylation levels of technical
replicates.
Most epimutations underlying the variation in DNA
methylation may occur after fertilization and probably
represent stochastic errors in the establishment or mainte-
nance of an epigenetic state. If an epimutation occurs
Figure 2. Association between age and H19, MEG3, LIT1, NESP55, SNRPN and PEG3 methylation. (A) Regression lines and data points represent
measurements in blood samples of unrelated healthy individuals between 21 and 72 years. R2 is the linear correlation coefficient. (B) Regression lines
when removing all samples from individuals up to 25 years.
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in the germline, all cells of the individual should
be affected, leading to clear DMR hypomethyla-
tion (<10%) or hypermethylation (>90%) in our
pyrosequencing assay. In contrast, if an epimutation
occurs during embryogenesis or later in life, it affects
only a subset of cells, resulting in somatic mosaicism.
The wide range of methylation variation in cis-regulatory
regions suggests the possibility that basically each cell
in a given tissue may be unique in its epigenomic
profile. Thus, epigenetic analyses are not only hampered
by the fact that only few tissues such as blood are
readily accessible, but also by the high degree of epi-
genetic mosaicism. Because bisulfite treatment heavily
degrades DNA, methylation analyses of single cells are
both technically challenging and time-consuming (56,57),
and therefore not particularly suitable for stud-
ying cell-to-cell variability in larger cell populations.
Currently available quantitative methylation assays
such as bisulfite pyrosequencing provide only a rough
estimate on the percentage of normally versus extremely
(hypo- or hyper)methylated cells in a tissue. In addition,
when interpreting the medical relevance of our data,
i.e. whether or not the observed methylation differences
influence gene expression, we have to take into account
that the analyzed tissues consist of different cell types and
heterogeneous cell populations. From single cell expres-
sion analyses it becomes increasingly clear that the
average cell does not exist (58,59).
With the notable exception of native chorionic
villi, which show differential methylation of the APC
promoter (47), several hundred analyzed CpGs in cultured
CVS, adult brain, blood and sperm all displayed <20%
methylation. Average promoter methylation ranged from
4% in sperm to 10% in cultured CVS. Interestingly, the
methylation patterns, that is the relative differences in
methylation among seven analyzed neighboring CpGs
also appeared to differ among tissues. For example, in
adult blood with an average CGI methylation of 6% the
median methylation decreased from 10% at CpG 6 to
4% at CpG 7, whereas in adult cortex with an average
CGI methylation of 7% it increased from 7% at CpG
6 to 10% at CpG 7. This tissue-specific fluctuation
between neighboring CpGs is much higher than the
technical noise (1.1±0.6% between replicates) of our
APC pyrosequencing assay and, therefore may represent
a true biological phenomenon, i.e. tissue- and develop-
mental stage-dependent differences in nucleosome posi-
tioning (60) and/or binding of specific transcription
factors (61). By discriminant analysis based on only a
few CpG sites in the APC promoter, we can correctly
predict the tissue type in most analyzed samples. More
sophisticated algorithms including multiple genes might
considerably improve discriminative power.
Collectively, our results highlight substantial variation
of DNA methylation at cis-regulatory regions among
apparently healthy individuals. Although the observed
hypo- and hypermethylation values may represent
normal variation, this does not necessarily imply that
they are biologically irrelevant. In a conceptually related
study on imprinted gene methylation in human abortions
and stillbirths (fetal muscle samples), we found
that MEG3 hypermethylation was associated with
downregulation of this gene and H19 hypermethylation
increased the likelihood for biallelic expression of the
autocrine growth factor IGF2 (62). In this context, it is
noteworthy that altered DMR methylation patterns and
Figure 3. Differences in gene-specific methylation levels between pairs of monozygotic (MZ) and dizygotic twins (DZ). (A) The box plots dis-
play the pairwise difference in DMR methylation of H19, MEG3, LIT1, NESP55, SNRPN and PEG3 between MZ (12 pairs) and DZ (14 pairs).
The median methylation difference is represented by a horizontal line. (B) ROC curve comparing the pairwise methylation differences of MZ
and DZ. The area under the curve indicates the discriminative power of pairwise methylation differences in six studied genes between the MZ
and DZ groups.
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relaxation of imprinting have been described in normal
populations. For example, about 10% of blood samples
from healthy individuals showed biallelic IGF2 expression
(63). Loss of IGF2 imprinting occurs in colorectal cancer
and many other tumor types. The observation that IGF2
was also dysregulated in normal mucosa and peripheral
blood lymphocytes of these cancer patients (64) promotes
the idea that relaxation of imprinting may predispose to
tumorigenesis and, by extrapolation, other complex
diseases. Most likely, the role of epigenetic changes for
phenotypic variation and disease susceptibility is largely
underestimated. Further research is needed to determine
the functional implications of the enormous DNA
methylation variation for the fine tuning of gene
regulation.
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